The diverse landscape of histone-mutant pediatric high-grade gliomas: A narrative review.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 5, doi. 10.4103/glioma.glioma_1_22
- By:
- Publication type:
- Article
Works matching IS 25896113 AND DT 2022 AND VI 5 AND IP 1
Results: 6
1
2
Tumor growth, angiogenesis, and invasion as clinical hallmarks of glioblastoma: A case report.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 39, doi. 10.4103/glioma.glioma_2_22
- By:
- Publication type:
- Article
3
Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 29, doi. 10.4103/glioma.glioma_6_22
- By:
- Publication type:
- Article
4
A novel nomogram based on DNA damage response-related gene expression in patients with O-6-methylguanine-DNA methyltransferase unmethylated glioblastoma receiving temozolomide chemotherapy: A population-based analysis.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 20, doi. 10.4103/glioma.glioma_3_22
- By:
- Publication type:
- Article
5
Glioma stem cells and their microenvironment: A narrative review on docking and transformation.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 12, doi. 10.4103/glioma.glioma_5_22
- By:
- Publication type:
- Article
6
New changes in pathological diagnosis of brain tumors in the modern molecular era.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 1, p. 1, doi. 10.4103/glioma.glioma_7_22
- By:
- Publication type:
- Article